Wave Life Sciences Ltd. Quarterly Operating Income (Loss) in USD from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Wave Life Sciences Ltd. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2014 to Q3 2024.
  • Wave Life Sciences Ltd. Operating Income (Loss) for the quarter ending September 30, 2024 was -$63.9M, a 1538% decline year-over-year.
  • Wave Life Sciences Ltd. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$152M, a 63.7% decline year-over-year.
  • Wave Life Sciences Ltd. annual Operating Income (Loss) for 2023 was -$68M, a 58.2% increase from 2022.
  • Wave Life Sciences Ltd. annual Operating Income (Loss) for 2022 was -$163M, a 28.1% decline from 2021.
  • Wave Life Sciences Ltd. annual Operating Income (Loss) for 2021 was -$127M, a 17.2% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$152M -$63.9M -$68.4M -1538% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$83.7M -$35M -$11.5M -49.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$72.2M -$34.5M -$4.17M -13.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$68M -$18.7M +$24.9M +57.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 -$92.9M $4.44M +$43.3M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$136M -$23.5M +$18.7M +44.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$155M -$30.3M +$7.81M +20.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$163M -$43.6M -$7.45M -20.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 -$155M -$38.9M -$31.3M -411% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$124M -$42.2M -$2.34M -5.87% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$122M -$38.1M +$5.38M +12.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 -$127M -$36.1M -$5.8M -19.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$121M -$7.61M +$26.8M +77.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$148M -$39.8M -$1.17M -3.03% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$147M -$43.5M +$6.52M +13% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$153M -$30.3M +$30.2M +49.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-03
Q3 2020 -$184M -$34.4M +$19.8M +36.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$203M -$38.7M +$6.96M +15.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$210M -$50M -$2.01M -4.18% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$208M -$60.5M -$11.6M -23.7% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-02
Q3 2019 -$197M -$54.2M -$15.9M -41.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$181M -$45.6M -$9.04M -24.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$172M -$48M -$12.2M -34.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$160M -$48.9M -$17.8M -57.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$142M -$38.2M -$11.9M -45.1% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$130M -$36.6M -$11.9M -48.2% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$118M -$35.8M -$15.6M -77% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 -$102M -$31.2M -$12.7M -68.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 -$89.7M -$26.4M -$9.12M -52.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-01
Q2 2017 -$80.6M -$24.7M -$13M -112% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-01
Q1 2017 -$67.6M -$20.2M -$12.3M -154% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-01
Q4 2016 -$55.3M -$18.5M -$11.3M -157% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-12
Q3 2016 -$44M -$17.2M -$12.2M -245% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-12
Q2 2016 -$31.8M -$11.6M -$8.01M -221% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-12
Q1 2016 -$23.8M -$7.95M -$4.49M -129% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-12
Q4 2015 -$19.3M -$7.21M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$4.99M -$3.64M -269% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-16
Q2 2015 -$3.63M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-16
Q1 2015 -$3.47M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-16
Q3 2014 -$1.35M Jul 1, 2014 Sep 30, 2014 10-Q 2015-12-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.